Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

Background. Iron deficiency anemia (IDA) is a common hematological complication with potentially serious clinical consequences that may require intravenous iron therapy. Ferric carboxymaltose (FCM) is a stable, nondextran iron formulation administered intravenously in large single doses to treat IDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Barish, Charles F., Koch, Todd, Butcher, Angelia, Morris, David, Bregman, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444829/
https://www.ncbi.nlm.nih.gov/pubmed/22997572
http://dx.doi.org/10.1155/2012/172104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444829/
https://www.ncbi.nlm.nih.gov/pubmed/22997572
http://dx.doi.org/10.1155/2012/172104

Ejemplares similares